Tyrosine Kinase(酪氨酸激酶)
- Bcr-Abl(70)
- Ack1(2)
- Axl(6)
- ALK(61)
- BMX Kinase(3)
- Broad Spectrum Protein Kinase Inhibitor(10)
- c-FMS(41)
- c-Kit(57)
- c-MET(92)
- c-RET(7)
- CSF-1R(3)
- DDR1/DDR2 Receptor(1)
- EGFR(264)
- EphB4(1)
- FAK(39)
- FGFR(103)
- FLT3(91)
- HER2(15)
- IGF1R(34)
- Insulin Receptor(45)
- IRAK(32)
- ITK(10)
- Lck(1)
- LRRK2(24)
- PDGFR(107)
- PTKs/RTKs(9)
- Pyk2(8)
- ROR(41)
- Spleen Tyrosine Kinase (Syk)(33)
- Src(101)
- Tie-2 (4)
- Trk(42)
- VEGFR(193)
- Discoidin Domain Receptor(16)
- DYRK(33)
- Ephrin Receptor(13)
- RET(29)
- ROS(14)
- TAM Receptor(32)
- IGFBR(1)
- Others(54)
- Cat.No. 产品名称 Information
-
GC12370
IKK-16 (hydrochloride)
IKK Inhibitor VII
IKK-16 (hydrochloride)是一种新型的、具有口服活性的选择性IκB激酶(IKK)抑制剂,IKK-16作用于IKK-2、IKK复合物和IKK-1的IC50值分别为40nM、70nM和200nM
-
GC17925
PKR-IN-C16
C16,GW 506033X,Protein Kinase RNA-activated
PKR-IN-C16是一种靶向ATP结合位点的小分子化合物,能够抑制RNA依赖性蛋白激酶(PKR)的自磷酸化,IC50值为0.21±0.04μM。
-
GC14054
SR 0987
An agonist of RORγt
-
GC10408
2-D08
2-D08是一种合成黄酮和具有细胞通透性的小泛素样修饰蛋白(SUMO)抑制剂,也能抑制Axl靶点,IC50为0.49nM。
-
GC12818
4-methyl Erlotinib
埃罗替尼杂质G
A methylated analog of erlotinib
-
GC10706
Rp-8-pCPT-Cyclic GMPS (sodium salt)
Rp-8-pCPT-cGMPS
A competitive inhibitor of cGK isoforms
-
GC10517
Rp-8-bromo-Cyclic GMPS (sodium salt)
Rp-8-bromo-cGMPS
A competitive inhibitor of cGK
-
GC15145
CEP-28122
An orally active ALK inhibitor
-
GC15314
PD 166326
An inhibitor of c-src and certain receptor tyrosine kinases, including c-abl
-
GC10938
AAL-993
VEGFR Tyrosine Kinase Inhibitor VI,ZK 260253
Inhibitor of VEGFR1, 2, and 3
-
GC13905
GSK2981278
An inverse agonist of RORγ
-
GC14544
JNJ-10198409
3-氟-N-(6,7-二甲氧基-2,4-二氢茚并[1,2-C〕吡唑-3-基)苯基胺
A potent PDGF tyrosine kinase inhibitor
-
GC10644
Neoruscogenin
新鲁斯可皂苷元
A bioavailable agonist of RORα
-
GC14418
SR 1555 (hydrochloride)
inverse agonist of RORγ
-
GC15280
Tivozanib (hydrate)
AV-951,KRN 951
A VEGFR inhibitor
-
GC16483
MAZ51
MAZ51是一种选择性血管内皮生长因子受体3(VEGFR-3;FLT4)酪氨酸激酶抑制剂。
-
GC11312
EGFR Inhibitor
Epidermal Growth Factor Receptor Inhibitor
A selective antagonist of the EGFR
-
GC14856
EGFR/ErbB2 Inhibitor
A dual inhibitor of EGFR and ErbB2
-
GC13961
ISCK03
STEM-CELLFACTOR/C-KIT抑制剂 ,c-Kit Inhibitor II,Stem-Cell Factor/c-Kit Inhibitor
An inhibitor of SCF/c-kit signaling
-
GC14103
NSC228155
An EGFR activator and inhibitor of KID-KIX interactions
-
GC15370
Olmutinib (HM61713, BI 1482694)
奥莫替尼
An inhibitor of mutant EGFR
-
GC12712
NT157
NT157是一种具有选择性的胰岛素受体底物-1/-2(IRS-1/2)抑制剂。
-
GC11726
BAW2881 (NVP-BAW2881)
BAW2881
A VEGFR inhibitor
-
GC15340
BFH772
An inhibitor of VEGFR2
-
GC15655
AMG 337
A selective c-Met inhibitor
-
GC15282
LOXO-101 (Larotrectinib) sulfate
(3S)-N-[5-[(2R)-2-(2,5-二氟苯基)-1-吡咯烷基]吡唑并[1,5-A]嘧啶-3-基]-3-羟基-1-吡咯烷甲酰胺硫酸盐,LOXO-101 sulfate; ARRY-470 sulfate
LOXO-101 (Larotrectinib) sulfate是一种口服可用的ATP竞争性泛TRK抑制剂,对TRKA和TRKC的IC50值分别为0.9nM和2.8nM。
-
GC11321
PRT-060318
PRT318
A potent and selective Syk inhibitor
-
GC15466
RO9021
RO9021 是一种具有口服生物利用度的新型 ATP 竞争性 SYK 抑制剂,平均 IC50 为 5.6 nM。
-
GC12038
RG 13022
Tyrphostin RG13022
An inhibitor of EGF receptor kinase
-
GC14582
SU5614
(3Z)-5-氯-3-[(3,5-二甲基-1H-吡咯-2-基)亚甲基]-1,3-二氢-2H-吲哚-2-酮
A multi-kinase inhibitor
-
GC12281
EAI045
A potent inhibitor of mutant EGFRs
-
GC10607
GNF-7
A multi-kinase inhibitor
-
GC17294
CHMFL-ABL-053
CHMFL-ABL-053 (Compound 18a) 是一种有效的、选择性的、可口服的 BCR-ABL、SRC 和 p38 激酶抑制剂,对 ABL1、SRC 和 p38 的 IC50 值分别为 70、90 和 62 nM。
-
GC14488
NPS-1034
2-(4-氟苯基)-N-[3-氟-4-[(3-苯基-1H-吡咯并[2,3-B]吡啶-4-基)氧基]苯基]-2,3-二氢-1,5-二甲基-3-氧代-1H-吡唑-4-甲酰胺
A dual MET/AXL inhibitor
-
GC13143
AZD3759
AZD3759
A brain penetrant inhibitor of EGFR
-
GC10165
Dovitinib (TKI258) Lactate Hydrate
多韦替尼,TKI258 lactate hydrate; CHIR-258 lactate hydrate
A multi-kinase inhibitor
-
GC14218
TP-0903
TP-0903
An Axl kinase inhibitor
-
GC17790
CL-387785 (EKI-785)
EKI-785; WAY-EKI 785
An irreversible inhibitor of EGFR kinase activity
-
GC16321
EGF816
那扎替尼; EGF816
An inhibitor of mutant EGFR
-
GC10355
Fruquintinib(HMPL-013)
呋喹替尼; HMPL-013
An inhibitor of VEGF1, -2, and -3
-
GC17772
BMS-817378
[3-[[4-((2-氨基-3-氯吡啶-4-基)氧基)-3-氟苯基]氨基甲酰基]-5-(4-氟苯基)-4-氧代-4H-吡啶-1-基]甲基磷酸二氢酯
Potent ATP competitive inhibitor of Met/VEGFR2
-
GC14476
Entrectinib
恩曲替尼; NMS-E628; RXDX-101
Entrectinib是一种具有口服活性、可穿透血脑屏障(BBB)且在中枢神经系统起作用的TrkA/B/C、ROS1与ALK抑制剂,其IC50值分别为1、3、5、12和7nM。
-
GC12222
Pexidartinib (PLX3397)
培西达替尼,PLX-3397
Pexidartinib(PLX3397) 是一种口服小分子酪氨酸激酶抑制剂,对集落刺激因子 1(CSF1) 受体 (IC50=20nM)、KIT 原癌基因受体酪氨酸激酶 (KIT)(IC50 = 10nM) 和类 FMS 酪氨酸激酶 3Pexidartinib 在体外是一种比伊马替尼更强的 KIT 抑制剂。
-
GC11140
Radotinib(IY-5511)
拉多替尼
A selective Bcr-Abl tyrosine kinase inhibitor
-
GC17637
CTX0294885
A broad spectrum kinase inhibitor used in proteomics
-
GC17669
AMG-47A
4-甲基-3-[2-[[2-(4-吗啉基)乙基]氨基]-6-喹唑啉基]-N-[3-(三氟甲基)苯基]苯甲酰胺
A multi-kinase inhibitor
-
GC17500
SU6656
SU6656是一种小分子吲哚酮类化合物,可选择性抑制Src、Yes和Fyn激酶活性,IC50值分别为0.28μM、0.02μM和0.17μM。
-
GC12955
AZ5104
奥西替尼中间体
An active metabolite of AZD 9291
-
GC17959
AZD2932
A multi-kinase inhibitor
-
GC16604
Altiratinib
DCC-2701
A multiple kinase inhibitor